Anticoagulant mechanism of sulfonated polyisoprenes
Source abstract
Abstract
The influence of sulfonated polyisoprene (SPIP) on coagulation factors and human blood cells was investigated to elucidate and compare its anticoagulant mechanism with that of heparin. While the number of red cells was unaffected, the number of platelets decreased dramatically in the presence of SPIP due to aggregation. Using a synthetic peptide substrate to assay thrombin activity in the presence of its natural inhibitor, antithrombin (AT), we observed no stimulation by SPIP of AT-mediated inhibition. Nevertheless, thrombin cleavage of its natural substrate fibrinogen to fibrin peptide A was slightly inhibited. SPIP altered the electrophoretic mobility of fibrinogen and completely inhibited fibrinogen from clotting. We detected no significant influence of SPIP on factors II, VII, IX, and X, while factor XI and factors V and VIII were only slightly affected. Therefore, the main mechanism of SPIP's anticoagulant activity appears to be a strong interaction with fibrinogen and fibrin monomer, first, to prevent proteolytic conversion of the former to the latter and second, to inhibit polymerization of the fibrin monomer, once formed.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Blood properties and coagulation · Lubricants and Their Additives · Platelet Disorders and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (37)
Show source-provided references
1. Complexes of heparin with elastomeric positive polyelectrolytes10.1002/jbm.820050210 ↗
2. Antithrombogenic polymers10.1351/pac198456101335 ↗
3. The search for thromboresistance using immobilized heparin10.1111/j.1749-6632.1987.tb33034.x ↗
4. Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials10.1016/0142-9612(94)90194-5 ↗
5. Heparin-induced thrombocytopenia10.1111/j.1365-2141.1995.tb08346.x ↗
6. Blood coagulation10.1038/167039a0 ↗
7. Antithrombin activity of a polyelectrolyte synthesized from cis-1,4-polyisoprene10.1002/jbm.820080605 ↗
8. Anticoagulant activity of sulfonate polymers and copolymers
9. New heparin-like insoluble materials10.1007/BF02364219 ↗
10. Synthetic polymers with anticoagulant activity
11. Anticoagulant activity of a synthetic heparinoid in relation to molecular weight and N-sulfate content10.1002/jbm.820150606 ↗
12. Antithrombic activity of some polysaccharide resins10.1016/0142-9612(82)90023-0 ↗
13. Heparin-like activity of insoluble sulfonated polystyrene resins. Part I10.1016/0142-9612(85)90085-7 ↗
14. Heparin-like activity of insoluble sulfonated polystyrene resins. Part III10.1016/0142-9612(87)90062-7 ↗
15. Effect of carboxylate and/or sulfonate ion incorporation on the physical and blood-contacting properties of a polyetherurethane10.1016/0142-9612(91)90115-Q ↗
16. Anticoagulant effects of sulphonated polyurethanes10.1016/0142-9612(92)90037-O ↗
17. Blood coagulation is inhibited by sulphated copolymers of vinyl alcohol and acrylic acid under in vitro as well as in vivo conditions10.1016/0049-3848(94)90154-6 ↗
18. Anticoagulant activity of dextran derivatives10.1002/(SICI)1097-4636(199807)41:1<49::AID-JBM6>3.0.CO;2-Q ↗
19. Structure-activity relationship of antithrombotic polysaccharide derivatives10.1016/0141-8130(96)81837-X ↗
20. Anticoagulant effects of sulfonated polyisoprenes10.1016/S0142-9612(97)00207-X ↗
21. Effect of sulfonated polyisoprene on blood chemical analysis
22. The purification and mechanism of action of human antithrombin–heparin cofactor10.1016/S0021-9258(19)43472-8 ↗
23. Involvement of heparin chain length in the heparin-catalyzed inhibition of thrombin by antithrombin III10.1016/S0021-9258(18)91066-5 ↗
24. Platelet adhesion onto microcapsule membranes with different degrees of sulfonation10.1002/jbm.820170607 ↗
25. Polyethylene surface sulfonation10.1006/jcis.1994.1147 ↗
26. Physical and blood-contacting properties of polyurethanes based on a sulfonic acid-containing diol chain extender10.1002/jbm.820251106 ↗
27. Properties and biological interactions of polyurethane anionomers10.1002/jbm.820230304 ↗
28. Effect of sulfonation of segmented polyurethanes on the transient adsorption of fibrinogen from plasma10.1002/jbm.820260105 ↗
29. Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins10.1016/0049-3848(82)90031-7 ↗
30. Catalysis of the generation of thrombin–antithrombin complex by insoluble anticoagulant polystyrene derivatives10.1016/0142-9612(84)90008-5 ↗
31. Measurement of the affinities of heparins, naturally occurring glycosaminoglycans, and other sulfated polymers for antithrombin III and thrombin10.1016/0003-2697(88)90533-7 ↗
32. Implications of the three-dimensional structure of a-antitrypsin for structure and function of seripins10.1021/bi00449a001 ↗
33. A fragment of antithrombin that binds both heparin and thrombin10.1042/bj2370639 ↗
34. Structure of the antithrombin-binding site in heparin10.1073/pnas.76.7.3198 ↗
35. Activation of human blood coagulation factor XI independent of factor XII10.1016/S0021-9258(20)89453-8 ↗
36. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin10.1073/pnas.86.17.6508 ↗
37. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor10.1016/S0021-9258(17)35234-1 ↗